PMID: 8597382Dec 29, 1995Paper

Cytokines in stem cell transplantation

Annals of the New York Academy of Sciences
F M Stewart

Abstract

The use of cytokines in stem cell transplantation is still in the early stages of development. Efficacy has not been established consistently at the present time. When cytokines are employed in the treatment setting, they should be employed in a study setting evaluating whether there has been real patient benefit-palliation without compromise of therapeutic outcome or, preferably, a survival advantage. Cost effectiveness has not been established and, in any case it should not be a consideration until therapeutic efficacy has been established. The determination of various biologic parameters on cells such as cytokine receptors may permit more precise use of HGFs. In some cases there probably are subsets of patients who are benefited, while there are subsets who are harmed. The challenge of the future is to define these subsets.

References

Jan 1, 1992·The American Journal of Pediatric Hematology/oncology·H E Broxmeyer
Feb 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·M MusashiM Ogawa
Jun 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M KörblingW Hunstein
May 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A S FreedmanL Heflin
Apr 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G SpitzerW McIntyre
Jun 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J CrownC Hudis

❮ Previous
Next ❯

Citations

Jun 15, 1999·Toxicologic Pathology·J C Schuh, P J Morrissey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.